Growth Failure Clinical Trial
Official title:
The Effect of Standard Versus High Energy Density, Low Volume Oral Nutritional Supplements in Children Requiring Nutritional Support - a Pilot Trial
Verified date | October 2017 |
Source | Nutricia UK Ltd |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is a pilot trial investigating the effects of a high energy drink for children, in comparison to standard energy drink for children.
Status | Completed |
Enrollment | 51 |
Est. completion date | August 2016 |
Est. primary completion date | August 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 1 Year to 12 Years |
Eligibility |
Inclusion Criteria: - Male or female - Aged 1-12yrs - Faltering growth and/or requiring oral nutritional supplements to meet nutritional requirements - Expected to receive at least one bottle of the study product per day - Able to take study products orally during the study period - Written informed consent from parent/carer Exclusion Criteria: - Requirement for 100% of their nutrition via enteral tube and/or parenteral feeding. - Children with major hepatic or renal dysfunction - Children with galactosaemia or severe lactose intolerance - Requirement for elemental or semi-elemental feeds - Investigator concern around willingness/ability of child/parent/carer to comply with protocol requirements - Participation in other studies within 2 weeks of study |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Nutricia UK Ltd |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Nutrient intake | Dietary intake, including the intake of all foods and fluids, will be recorded and analysed throughout the study. | 4 weeks (28 days) | |
Secondary | Compliance: Compliance with oral nutritional supplements in Group A and Group B; how much of the oral nutritional supplement is taken in comparison to the amount advised by the Dietitian. | 4 weeks (28 days) | ||
Secondary | Tolerance: How well the child tolerates the oral nutritional supplements (including changes to gastrointestinal symptoms) | 4 weeks (28 days) | ||
Secondary | Acceptability: How acceptable the oral nutritional supplement is to the child and their parent/carer, including taste, texture, ease of use, etc. | 4 weeks (28 days) | ||
Secondary | Anthropometry | Changes to weight, height and head circumference in children less than 2yrs of age. | 4 weeks (28 days) | |
Secondary | Safety assessed by adverse events, to be recorded throughout study. | 4 weeks (28 days) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04226586 -
Nutritional Stimulation of Growth in Children With Short Stature
|
N/A | |
Terminated |
NCT03016195 -
Evaluation of the Normal Range of Urinary Sodium Levels in Healthy Newborn Babies
|
N/A | |
Active, not recruiting |
NCT01809548 -
Preterm Infants on Early Solid Foods
|
N/A | |
Completed |
NCT01475357 -
Intestinal Function in Neonates With Complex Congenital Heart Disease
|
N/A | |
Completed |
NCT02136966 -
Joint Infant and Young Child Nutrition Program and Malnutrition Prevention
|
N/A | |
Active, not recruiting |
NCT04565314 -
ELICIT 2.0: Pilot Study of the Effect of Maternal Protein Supplementation During Lactation on Childhood Growth
|
N/A | |
Recruiting |
NCT04809350 -
Human Milk Fortification With Adjustable Versus Targeted Method
|
N/A | |
Completed |
NCT02515266 -
Additional Protein Fortification in Extremely Low Birth Weight Infants
|
N/A | |
Recruiting |
NCT04294368 -
Targeted Fortification of Donor Breast Milk in Preterm Infants
|
N/A | |
Terminated |
NCT03532555 -
Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia
|
N/A | |
Withdrawn |
NCT02999945 -
Optimal Growth of Preterm Infants With Growth Restriction
|
N/A | |
Completed |
NCT01909661 -
Tolerance of Infants With Cow's Milk Protein Allergy to Extensively Hydrolyzed Rice Protein or Casein Infant Formulas
|
Phase 2 | |
Not yet recruiting |
NCT04640805 -
Targeted Fortification of Pasteurized Donor Human Milk
|
N/A | |
Completed |
NCT01603368 -
Prophylactic Probiotics to Extremely Low Birth Weight Prematures
|
Phase 2 | |
Withdrawn |
NCT01314508 -
Increlex Treatment of Children With Chronic Liver Disease and Short Stature
|
N/A | |
Terminated |
NCT00490100 -
Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1
|
Phase 1/Phase 2 | |
Completed |
NCT04587271 -
Nutritional Impact of Moringa Oleifera Leaf Supplementation in Mothers and Children
|
N/A | |
Completed |
NCT01034735 -
r-hGH Liquid Multidose Versus Freeze-dried Multidose Bioequivalence Trial
|
Phase 1 | |
Active, not recruiting |
NCT03761498 -
Is There a Microbiome Associated With Poor Growth in Preterm Infants?
|
||
Not yet recruiting |
NCT03522558 -
Medical Nutrition Therapy for Medically Complex Infants in the Pediatric Outpatient Setting
|
N/A |